These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 6973730

  • 1. Control of intractable atonic postpartum hemorrhage by 15-methyl prostaglandin F2 alpha.
    Toppozada M, El-Bossaty M, El-Rahman HA, El-Din AH.
    Obstet Gynecol; 1981 Sep; 58(3):327-30. PubMed ID: 6973730
    [Abstract] [Full Text] [Related]

  • 2. Management of severe postpartum hemorrhage due to uterine atony using an analogue of prostaglandin F2 alpha.
    Hayashi RH, Castillo MS, Noah ML.
    Obstet Gynecol; 1981 Oct; 58(4):426-9. PubMed ID: 6974335
    [Abstract] [Full Text] [Related]

  • 3. Management of severe postpartum hemorrhage with a prostaglandin F2 alpha analogue.
    Hayashi RH, Castillo MS, Noah ML.
    Obstet Gynecol; 1984 Jun; 63(6):806-8. PubMed ID: 6610143
    [Abstract] [Full Text] [Related]

  • 4. Control of postpartum uterine atony by intramyometrial prostaglandin.
    Bruce SL, Paul RH, Van Dorsten JP.
    Obstet Gynecol; 1982 Jun; 59(6 Suppl):47S-50S. PubMed ID: 6979727
    [Abstract] [Full Text] [Related]

  • 5. Local administration of (15 S)-15-methyl PGF2 alpha for management of hypotonic post-partum hemorrhage.
    Thiery M, Parewijck W.
    Z Geburtshilfe Perinatol; 1985 Jun; 189(4):179-80. PubMed ID: 3876658
    [Abstract] [Full Text] [Related]

  • 6. The use of 15 methyl F2 alpha prostaglandin (Prostin 15M) for the control of postpartum hemorrhage.
    Buttino L, Garite TJ.
    Am J Perinatol; 1986 Jul; 3(3):241-3. PubMed ID: 3487334
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intramyometrial prostaglandin F2 alpha in the treatment of severe postpartum hemorrhage.
    Jacobs MM, Arias F.
    Obstet Gynecol; 1980 May; 55(5):665-6. PubMed ID: 6966043
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of severe postpartum atony with prostaglandin].
    Høgdall CK, Høgdall E.
    Ugeskr Laeger; 1989 Sep 18; 151(38):2410-3. PubMed ID: 2678650
    [Abstract] [Full Text] [Related]

  • 15. [Use of prostaglandin F 2-alpha in placental period (author's transl)].
    Halle H, Hengst P.
    Zentralbl Gynakol; 1979 Sep 18; 101(14):916-7. PubMed ID: 316951
    [Abstract] [Full Text] [Related]

  • 16. Use of 15-methyl prostaglandin F2 alpha postpartum to contract the uterus in normal pregnant women.
    Nelson GH.
    J Med Assoc Ga; 1983 Oct 18; 72(10):703-6. PubMed ID: 6644193
    [No Abstract] [Full Text] [Related]

  • 17. [Administration of 15-(S)-15-methyl prostaglandins F2 alpha in intrauterine fetal death, missed abortion and hydatidiform mole (author's transl)].
    Husslein P, Reinold E.
    Wien Klin Wochenschr; 1979 Jun 22; 91(13):458-60. PubMed ID: 463045
    [Abstract] [Full Text] [Related]

  • 18. Clinical obstetric use of arachidonic acid metabolites and potential adverse effects.
    Jacobs MM.
    Semin Perinatol; 1986 Oct 22; 10(4):299-315. PubMed ID: 3494311
    [No Abstract] [Full Text] [Related]

  • 19. [Induction for termination of pregnancy in the second trimester and for delivery of babies dead in utero using intramuscular injections of 15-methyl-PGF2 alpha (author's transl)].
    Kunz B, De Grandi P.
    J Gynecol Obstet Biol Reprod (Paris); 1981 Oct 22; 10(4):375-84. PubMed ID: 7299101
    [Abstract] [Full Text] [Related]

  • 20. Prostaglandins--lifesaving drugs for postpartum uterine atony.
    Catanzarite VA.
    West J Med; 1986 Apr 22; 144(4):477. PubMed ID: 3487174
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.